EIQ - FDA meeting sets out approval pathway for Heart Failure tech - Next Investors
Our AI heart disease detection Investment EchoIQ (ASX: EIQ) just put out an update on its Heart Failure product. EIQ already has FDA clearance for ...
Read the original at Next Investors ↗
- Topics
- HealthcareMarkets & Investment
- Mentions
- FDA
- Tracked via
- “AI Falures”